日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proprotein convertase subtilisin/kexin type 9-CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery disease

前蛋白转化酶枯草杆菌蛋白酶/kexin 9型-CC基序趋化因子配体2相互作用将脂蛋白(a)组成与冠状动脉疾病中的中间单核细胞炎症联系起来

Ugovšek, Sabina; Rehberger Likozar, Andreja; Levstek, Tina; Trebušak Podkrajšek, Katarina; Zupan, Janja; Marka, Frieda; Trimmel, Tamara; Brekalo, Mira; Speidl, Walter; Hohensinner, Philipp; Haider, Patrick; Šebeštjen, Miran

Telomere Length, Oxidative Stress, and Kidney Damage Biomarkers in Fabry Nephropathy

法布里肾病中的端粒长度、氧化应激和肾损伤生物标志物

Levstek, Tina; Bahčič, Erazem; Vujkovac, Bojan; Cokan Vujkovac, Andreja; Tesovnik, Tine; Remec, Žiga Iztok; Čuk, Vanja; Trebušak Podkrajšek, Katarina

Gain of function variants in PCSK9 gene in high risk patients after myocardial infarction with increased lipoprotein (a) values and treated with statins.

PCSK9 基因功能获得性变异在心肌梗死后高危患者中,伴有脂蛋白 (a) 值升高,并接受他汀类药物治疗

Ugovšek Sabina, Likozar Andreja Rehberger, Levstek Tina, Podkrajšek Katarina Trebušak, Zupan Janja, Antonić Slobodan, Šebeštjen Miran

Treatment with PCSK9 inhibitors influences microRNAs expression and changes of arterial wall properties: a randomized controlled trial

PCSK9抑制剂治疗影响microRNA表达和动脉壁特性变化:一项随机对照试验

Rehberger Likozar, Andreja; Levstek, Tina; Karun, Tina; Trebušak Podkrajšek, Katarina; Zupan, Janja; Šebeštjen, Miran

Transcriptomic Approach in Understanding Fabry Nephropathy: A Review of the Literature and Proof-of-Concept

转录组学方法在理解法布里肾病中的应用:文献综述和概念验证

Breznik, Nika; Levstek, Tina; Vujkovac, Bojan; Cokan Vujkovac, Andreja; Trebušak Podkrajšek, Katarina

Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values.

脂蛋白(a)基因变异rs10455872和rs3798220的单倍型与心肌梗死后患者凝血、纤溶和炎症参数以及脂蛋白(a)值高度升高相关

Ugovšek Sabina, Rehberger Likozar Andreja, Levstek Tina, Trebušak Podkrajšek Katarina, Zupan Janja, Šebeštjen Miran

Dynamics of Leukocyte Telomere Length in Patients with Fabry Disease

法布里病患者白细胞端粒长度的动态变化

Levstek, Tina; Breznik, Nika; Vujkovac, Bojan; Nowak, Albina; Trebušak Podkrajšek, Katarina

Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy

尿液来源的细胞外囊泡揭示了一种独特的microRNA特征,该特征与法布里肾病的发生发展相关。

Levstek, Tina; Vujkovac, Bojan; Cokan Vujkovac, Andreja; Trebušak Podkrajšek, Katarina

Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors.

接受 PCSK9 抑制剂治疗的极高脂蛋白(a)患者的微小RNA、血清前蛋白转化酶枯草杆菌蛋白酶/Kexin 9 型 (PCSK9) 和脂质参数之间的相互作用

Levstek Tina, Karun Tina, Rehberger Likozar Andreja, Šebeštjen Miran, Trebušak Podkrajšek Katarina

The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels

PCSK9抑制剂治疗及CRP(rs1800947)、TNFA(rs1800629)和IL6(rs1800795)基因变异对高脂蛋白(a)水平患者相应炎症标志物的影响

Levstek, Tina; Podkrajšek, Nik; Rehberger Likozar, Andreja; Šebeštjen, Miran; Trebušak Podkrajšek, Katarina